A Phase 2, Multicenter, Randomized, Parallel-Group, Double-Masked, 4-Arm, Sham-Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 Administered by Intravitreal Injection in Patients with Geographic Atrophy (GA) Secondary to AMD
Research Grant
Administered By
Ophthalmology
Awarded By
Annexon Biosciences
Start Date
November 30, 2020
End Date
June 30, 2024
Administered By
Ophthalmology
Awarded By
Annexon Biosciences
Start Date
November 30, 2020
End Date
June 30, 2024